Calendar Legend Biotech Corporation

Equities

LEGN

US52490G1022

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 08/07/2025 BST			5-day change	1st Jan Change
37.49 ^USD	+4.52%		+3.31%	+15.21%

07-03	UBS Lowers Price Target on Legend Biotech to $54 From $60, Maintains Buy Rating	MT
06-30	Legend Biotech Provides Update on REMS for Currently Approves BCMA- and CD19-Directed Autologous Chimeric Antigen Receptor T Cell Immunotherapies	CI

Chart calendar Legend Biotech Corporation

634258.ZdHKvRkd721uN9c5vH2ieRu1FbsKYWudkUdgVzvSUvw.DaiLj1JntjQFZYRo5BHgKW_Bbd47DhHZ9jdWOl_mY4Uh6POJLGi4GS9Thg~871ce5dd0deccde15df6903316ed1e68

Upcoming events on Legend Biotech Corporation

28/08/2025	Q2 2025 Earnings Release (Projected)
23/11/2025	Q3 2025 Earnings Release (Projected)
17/03/2026	Q4 2025 Earnings Release (Projected)
18/05/2026	Q1 2026 Earnings Release (Projected)

Past events on Legend Biotech Corporation

14/06/2025 17:30	European Hematology Association Congress - Abstract No: #PS1723
14/06/2025 17:30	European Hematology Association Congress - Abstract No: #PS1728
13/06/2025 17:30	European Hematology Association Congress - Abstract No: #PF765
12/06/2025 16:00	European Hematology Association Congress - Abstract No: #S192
12/06/2025 14:00	Annual General Meeting
03/06/2025 17:57	American Society of Clinical Oncology Meeting - Abstract No : #7507
02/06/2025 00:00	American Society of Clinical Oncology Meeting
01/06/2025 15:00	American Society of Clinical Oncology Meeting - Abstract No : #7539
31/05/2025 19:30	American Society of Clinical Oncology Meeting - Abstract No : #8104
31/05/2025 15:00	American Society of Clinical Oncology Meeting - Abstract No : #4022
16/05/2025 22:00	American Society of Gene & Cell Therapy Meeting - Abstract No : #339
13/05/2025 13:00	Q1 2025 Earnings Call
13/05/2025 12:00	Q1 2025 Earnings Release
11/03/2025 12:00	Q4 2024 Earnings Call
11/03/2025 11:00	Q4 2024 Earnings Release
14/01/2025 23:45	JP Morgan Healthcare Conference
10/12/2024 01:45	American Society of Hematology Meeting - Oral : 1032
09/12/2024 04:00	American Society of Hematology Meeting - Poster No - 3390
09/12/2024 02:00	American Society of Hematology Meeting - Poster No - 3390
08/12/2024 02:00	American Society of Hematology Meeting - Poster No - 2002

Annual results

Fiscal Period	December	2022	2023	2024	2025	2026	2027
Net sales Million USD	Released Forecast Spread	117 132 -11.08%	285 296 -3.82%	627 616 1.87%	1 023	1 569	2 106
EBITDA Million USD	Released Forecast Spread	-443 -305 -45.35%	-392 -420 6.65%	-113 -269 57.98%	-123	180	481
EBIT Million USD	Released Forecast Spread	-456 -424 -7.4%	-413 -458 9.85%	-137 -286 52.29%	-146	164	513
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-446 -437 -1.97%	-520 -487 -6.75%	-158 -277 42.94%	-142	191	514
Net income Million USD	Released Forecast Spread	-446 -437 -2.06%	-518 -482 -7.55%	-177 -280 36.85%	-143	177	489
EPS USD	Released Forecast Spread	-2,80 -2,79 -0.36%	-2,94 -2,84 -3.57%	-0,96 -1,32 27.12%	-0,93	0,47	1,10
Announcement Date		30/03/23	11/03/24	11/03/25	-

Quarterly results

Fiscal Period	March	2023 Q3	2023 Q4	2024 Q1	2024 Q2	2024 Q3	2024 Q4	2025 Q1	2025 Q2	2025 Q3	2025 Q4	2026 Q1	2026 Q2	2026 Q3	2026 Q4	2027 Q1
Net sales Million USD	Released Forecast Spread	96,0 99,5 -3.51%	79,5 95,7 -16.93%	94,0 141 -33.51%	187 126 47.91%	160 146 9.67%	187 179 4.2%	195 194 0.61%	232	270	327	329	410	403	454	523
EBITDA Million USD	Released Forecast Spread	-53,6 -132 59.36%		-48,6 -77,4 37.24%	-36,6 -101 63.85%	-110 -101 -9.25%	52,5 -110 147.69%	-88,9 -65,2 -36.22%	-51,4	-23,8	-5,92	-17,0	7,00	13,0	20,0	95,8
EBIT Million USD	Released Forecast Spread	-56,8 -122 53.37%	-141 -124 -13.65%	-54,3 -63,1 13.98%	-42,0 -89,0 52.86%	-115 -101 -14.47%	45,7 -72,8 162.75%	-94,1 -77,1 -22.08%	-49,5	-31,4	-13,6	-18,2	5,44	16,1	32,2	94,2
Earnings before Tax (EBT) Million USD	Released Forecast Spread	-62,5 -109 42.44%	-147 -122 -19.94%	-59,8 -69,7 14.2%	-18,0 -85,4 78.95%	-121 -98,8 -22.38%	40,5 -87,3 146.42%	-99,1 -72,7 -36.4%	-34,9	-21,6	6,09	-4,73	73,0	34,7	64,8	94,2
Net income Million USD	Released Forecast Spread	-62,2 -109 42.75%	-145 -112 -29.27%	-59,8 -69,4 13.89%	-18,2 -92,3 80.29%	-125 -98,9 -26.71%	26,3 -85,9 130.61%	-101 -72,6 -38.93%	-32,8	-23,7	3,11	-6,16	71,5	33,3	63,3	94,2
EPS USD	Released Forecast Spread	-0,34 -0,54 37.04%	-0,80 -0,67 -19.4%	-0,32 -0,32 -1.59%	-0,10 -0,45 77.78%	-0,68 -0,58 -17.24%	0,14 -0,41 134.15%	-0,54 -0,26 -107.69%	-0,21	-0,14	-0,07	-0,06	0,08	0,14	0,22
Announcement Date		20/11/23	11/03/24	13/05/24	09/08/24	12/11/24	11/03/25	13/05/25	-	-	-	-	-	-	-	-

Upcoming sector events for Legend Biotech Corporation

09/07/2025	NURIX THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
22/07/2025	VIKING THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
28/07/2025	WUXI APPTEC CO., LTD.: Q2 2025 Earnings Release
29/07/2025	CASSAVA SCIENCES, INC.: Q2 2025 Earnings Release (Projected)
29/07/2025	XENCOR, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	DYNE THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KURA ONCOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	SANA BIOTECHNOLOGY, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	KEROS THERAPEUTICS, INC.: Q2 2025 Earnings Release (Projected)
30/07/2025	INSMED INCORPORATED: Q2 2025 Earnings Release (Projected)

More events

Past sector events for Legend Biotech Corporation

05/07/2025 03:24	PHARMAESSENTIA CORPORATION: June 2025 Sales and Revenue Release
02/07/2025	KALVISTA PHARMACEUTICALS, INC.: Q4 2025 Earnings Release (Projected)
12/06/2025	SANBIO COMPANY LIMITED: Q1 2025 Earnings Release
09/06/2025 07:46	LUMOSA THERAPEUTICS CO., LTD.: May 2025 Sales and Revenue Release
05/06/2025 09:21	PHARMAESSENTIA CORPORATION: May 2025 Sales and Revenue Release
05/06/2025 08:46	TAIMED BIOLOGICS INC.: May 2025 Sales and Revenue Release
15/05/2025 13:00	TAYSHA GENE THERAPIES, INC.: Q1 2025 Earnings Release
14/05/2025	LIGACHEM BIOSCIENCES INC.: Q1 2025 Earnings Release
14/05/2025	PEPTRON, INC.: Q1 2025 Earnings Release
14/05/2025	OLIX PHARMACEUTICALS, INC: Q1 2025 Earnings Release